![Kevin Lynch](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Kevin Patrick Lynch worked as a Vice President at Celgene Corp.
from 2011 to 2019.
He also worked as a Medical Director-Oncology at Novartis Pharmaceuticals Australia Pty Ltd. and as an Executive Director & Chief Medical Officer at Antengene Corp.
Ltd. in 2021.
Anciens postes connus de Kevin Lynch
| Sociétés | Poste | Fin |
|---|---|---|
| ANTENGENE CORPORATION LIMITED | Directeur Technique/Scientifique/R&D | 16/12/2022 |
| CELGENE | Corporate Officer/Principal | 01/01/2019 |
Novartis Pharmaceuticals Australia Pty Ltd.
 Novartis Pharmaceuticals Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Pharmaceuticals Australia Pty Ltd. is a company based in Sydney, Australia. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
56
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Novartis Pharmaceuticals Australia Pty Ltd.
Novartis Pharmaceuticals Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Pharmaceuticals Australia Pty Ltd. is a company based in Sydney, Australia. | Health Technology |
Antengene Corp. Ltd.
 Antengene Corp. Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes hematologic malignancies therapies | Health Technology |
